Humacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 48% ownership, public companies own 18% [Yahoo! Finance]
Humacyte, Inc. (HUMA)
Company Research
Source: Yahoo! Finance
The top 22 shareholders own 50% of the company Insiders own 12% of Humacyte To get a sense of who is truly in control of Humacyte, Inc. ( NASDAQ:HUMA ), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's share in the company with 48% ownership. Put another way, the group faces the maximum upside potential (or downside risk). Meanwhile, public companies make up 18% of the company's shareholders. Let's delve deeper into each type of owner of Humacyte, beginning with the chart below. Check out our latest analysis for Humacyte What Does The Institutional Ownership Tell Us About Humacyte? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. We can see that Humacyte does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the co
Show less
Read more
Impact Snapshot
Event Time:
HUMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUMA alerts
High impacting Humacyte, Inc. news events
Weekly update
A roundup of the hottest topics
HUMA
News
- Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024 [Yahoo! Finance]Yahoo! Finance
- Humacyte, Inc. (NASDAQ: HUMA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.MarketBeat
- Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024GlobeNewswire
- Humacyte, Inc. (NASDAQ: HUMA) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $4.00 price target on the stock.MarketBeat
- Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.MarketBeat
HUMA
Earnings
- 3/22/24 - Beat
HUMA
Sec Filings
- 3/28/24 - Form S-8
- 3/28/24 - Form 10-K
- 3/22/24 - Form 8-K
- HUMA's page on the SEC website